Black Rock Inc. Rvl Pharmaceuticals PLC Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.08 - $0.55 $489 - $3,362	-6,114 Reduced 2.64%	225,727 $20,000
Q2 2023 Aug 11, 2023	BUY	$0.56 - $1.17 $10,250 - $21,415	18,304 Added 8.57%	231,841 $129,000
Q1 2023 May 12, 2023	BUY	$1.02 - $1.39 $11,112 - $15,144	10,895 Added 5.38%	213,537 $243,000
Q4 2022 Feb 13, 2023	BUY	$1.02 - $1.61 $1,247 - $1,969	1,223 Added 0.61%	202,642 $226,000
Q3 2022 Nov 14, 2022	SELL	$1.28 - $2.91 $7,371 - $16,758	-5,759 Reduced 2.78%	201,419 $423,000
Q2 2022 Aug 12, 2022	SELL	$1.21 - $1.81 $6,060 - $9,066	-5,009 Reduced 2.36%	207,178 $282,000
Q1 2022 May 12, 2022	BUY	$1.03 - $2.01 $55,944 - $109,173	54,315 Added 34.4%	212,187 $358,000
Q4 2021 Feb 10, 2022	SELL	$0.98 - $3.06 $12,377 - $38,647	-12,630 Reduced 7.41%	157,872 $172,000
Q3 2021 Nov 09, 2021	BUY	$2.79 - $4.19 $9,073 - $13,625	3,252 Added 1.94%	170,502 $503,000
Q2 2021 Aug 11, 2021	BUY	$2.8 - $3.78 $468,299 - $632,205	167,250 New	167,250 $503,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.